
The third phase of clinical trials of Russia’s Sputnik V vaccine has begun after the country registered the vaccine in August before completing the trials — a move that has drawn criticism. CNN’s Matthew Chance goes inside the critical final trials that would establish the vaccine for public use.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push